Effect of Doxycycline on clinical improvement and outcome in patients with COVID-19

Phase 3

• Conditions: Covid 19.; Coronavirus infection, unspecified; B34.2

• Registration Number: IRCT20201117049427N1
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 August 2022

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 180

Inclusion Criteria

Age higher than 18 years
Definitive diagnosis of Covid 19
Having informed satisfaction

Exclusion Criteria

Allergy to Doxycycline
Chronic liver disease
Chronic kidney disease
History of lupus
History of porphyria
Pregnancy and lactation

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Duration of hospitalization. Timepoint: Before the intervention and 5 days after the intervention. Method of measurement: Checklist.;ICU admission. Timepoint: Before the intervention and 5 days after the intervention. Method of measurement: Checklist.